project id: TCGA-STAD; case submitter id: TCGA-VQ-A92D; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.01; rna integrity number: 8.6; age at index: 67; days to birth: -24595; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1942; age at diagnosis: 24595; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2032.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8211/3; primary diagnosis: Tubular adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1595; days to sample procurement: 0; initial weight: 470.0; portion submitter id: TCGA-VQ-A92D-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 2.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 23.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;